PET

Kyan Younes1, Emily Johns1, Christina B Young1

  • 1Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, California, USA.

概括

粉样蛋白PET扫描是阿尔茨海默病 (AD) 进展的有价值的预后标志物. 较高的粉样蛋白负担预测了不同患者群体的认知衰退和功能障碍.